American Herbal Products Association (AHPA) > News > Latest News

FDA posts final import and produce regulations to implement FSMA (FDA)

AHPA Legal Alert

The final rules establish enforceable safety standards for produce farms -- Produce Safety rule -- and make importers accountable for verifying that imported food meets U.S. safety standards -- Foreign Supplier Verification Programs (FSVP) rule. FDA also issued a rule establishing a program for the accreditation of third-party certification bodies, also known as auditors, to conduct food safety audits of foreign food facilities -- Accredited Third-Party Certification rule.

FDA solicits comments on use of "natural" on food labeling (FDA)

AHPA Legal Alert

In response to four Citizen Petitions and the evolution of food ingredients, the Food and Drug Administration (FDA) is soliciting comments on the use of the term "natural" on food labeling.

AHPA expresses opposition to mandatory product registration

AHPA restates recommendation to submit labels to existing federal database

"The existing Dietary Supplement Label Database is an effective platform to provide consumers with the same type of information that would be provided by mandatory product registration," said AHPA President Michael McGuffin.

Educating small natural products businesses is key to keeping the industry strong in the November 2015 AHPA Report

Log in to access this AHPA Report

Former FDA official calls for new regulatory framework for dietary supplements

Editor's Note: Former FDA official Joshua Sharfstein is calling for a new regulatory framework for dietary supplements. In an article published in Drug Testing and Analysis, Sharfstein and his co-author, Akshay Kapoor, allege that the regulation of dietary supplements has not kept up with changes and risks in the market, which has ultimately led to policy gridlock. He proposes a conceptual shift from 'benefit versus risk' to 'access with safety,' which includes registration of all dietary supplements, a disclaimer on the limited role of FDA in evaluating product claims, standardized laboratory techniques, and clearer authority for the agency when safety concerns arise.

AHPA kombucha education program supports industry compliance

Kombucha experts provide guidance and resources

AHPA presented three webinars as part of its recently launched kombucha education program aimed at encouraging and supporting compliance with kombucha manufacturing, labeling, and sales regulations

Kombucha: Tax, labeling and legislation

Presented: November 4, 2015

The third in a series of kombucha webinars provides regulatory and technical guidance to the kombucha industry from several industry legal experts.

Cannabinoids for Medical Use: A Systematic Review and Meta-analysis (JAMA)

Editor's Note: This review and analysis of cannabinoids for medical use found moderate-quality evidence to support the use of cannabinoids for the treatment of chronic pain and spasticity. There was low-quality evidence suggesting that cannabinoids were associated with improvements in nausea and vomiting due to chemotherapy, weight gain in HIV, sleep disorders, and Tourette syndrome. Cannabinoids were associated with an increased risk of short-term adverse events.
   

NIH Office of Dietary Supplements seeks comments on Dietary Supplement Label Database

Color additive regulations expand the permitted use of spirulina extract (Federal Register)

Editor's Note: The FDA has confirmed the effective date as September 22, 2015, for the Final Rule that amended the color additive regulations to expand the permitted use of spirulina extract as a color additive to include use in coating formulations applied to dietary supplement and drug tablets and capsules. FDA received no objections or requests for a hearing on the final rule. 

RSS
First 891011121314151617 Last

2017 Annual Fund Sponsors

           

AHPA appreciates the support of its sponsors, but does not endorse, recommend, or provide a warranty for any sponsor company, its products or services. AHPA has no responsibility for any transaction entered into with any of these companies.